Myopathy associated with anticonvulsant osteomalacia.
D000328:Adult; D000927:Anticonvulsants / Q000009:adverse effects*; D001416:Back Pain / Q000209:etiology*; D003863:Depression; D004569:Electroencephalography; D004576:Electromyography; D004872:Ergocalciferols / Q000627:therapeutic use; D005260:Female; D005492:Folic Acid / Q000627:therapeutic use; D006454:Hemoglobins; D006801:Humans; D007360:Intelligence; D008854:Microscopy, Electron; D009135:Muscular Diseases / Q000139:chemically induced*; D010018:Osteomalacia / Q000150:complications*; D010243:Paralysis / Q000139:chemically induced*; D010634:Phenobarbital / Q000009:adverse effects; D010672:Phenytoin / Q000009:adverse effects; D013843:Thiazines / Q000009:adverse effects; D014807:Vitamin D / Q000627:therapeutic use
D000927:Anticonvulsants; D004872:Ergocalciferols; D006454:Hemoglobins; D013843:Thiazines; D014807:Vitamin D; D010672:Phenytoin; D005492:Folic Acid; D010634:Phenobarbital